An Updated Understanding of the Role of YAP in Driving Oncogenic Responses
Giampaolo Morciano1, Bianca Vezzani1, Sonia Missiroli1
1Laboratory for Technologies of Advanced Therapies (LTTA), Section of Experimental Medicine, Department of Medical Science, University of Ferrara, 44121 Ferrara, Italy.
Abstract:
Yes-associated protein (YAP) has emerged as a key component in cancer signaling and is considered a potent oncogene. As such, nuclear YAP participates in complex and only partially understood molecular cascades that are responsible for the oncogenic response by regulating multiple processes, including cell transformation, tumor growth, migration, and metastasis, and by acting as an important mediator of immune and cancer cell interactions. YAP is finely regulated at multiple levels, and its localization in cells in terms of cytoplasm-nucleus shuttling (and vice versa) sheds light on interesting novel anticancer treatment opportunities and putative unconventional functions of the protein when retained in the cytosol. This review aims to summarize and present the state of the art knowledge about the role of YAP in cancer signaling, first focusing on how YAP differs from WW domain-containing transcription regulator 1 (WWTR1, also named as TAZ) and which upstream factors regulate it; then, this review focuses on the role of YAP in different cancer stages and in the crosstalk between immune and cancer cells as well as growing translational strategies derived from its inhibitory and synergistic effects with existing chemo-, immuno- and radiotherapies.
Insights
Yes-associated protein (YAP) is a key oncogene in cancer, regulating tumor growth and metastasis. Understanding YAP
Area of Science:
- Oncology and Molecular Biology
- Cancer Signaling Pathways
- Cellular Regulation
Background:
- Yes-associated protein (YAP) is a potent oncogene central to cancer signaling.
- Nuclear YAP drives oncogenic processes like cell transformation, tumor growth, migration, and metastasis.
- YAP also mediates crucial interactions between immune and cancer cells.
Purpose of the Study:
- To review the current knowledge on YAP's role in cancer signaling.
- To differentiate YAP from WWTR1/TAZ and identify its upstream regulators.
- To explore YAP's involvement in various cancer stages, immune-cancer crosstalk, and therapeutic strategies.
Main Methods:
- Literature review and synthesis of existing research on YAP.
- Comparative analysis of YAP and WWTR1/TAZ functions.
- Examination of YAP's role in cancer progression and therapeutic interventions.
Main Results:
- YAP's complex regulatory mechanisms and its cytoplasmic retention offer novel therapeutic insights.
- YAP's distinct functions compared to WWTR1/TAZ are highlighted.
- YAP's multifaceted role across cancer stages and its interaction with therapies are detailed.
Conclusions:
- YAP is a critical oncogene with diverse roles in cancer development and progression.
- Understanding YAP regulation and localization is key to developing new anticancer treatments.
- Targeting YAP, alone or in combination with existing therapies, presents promising translational strategies.
More Related Videos
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mechanisms of Retrovirus-induced Cancers
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
